News
A good tablet can change how you live your life. If you're going to invest big bucks in a 12-inch-plus model, you should know ...
Dailymotion on MSN7d
How issues linked to growth in Sydney’s west will influence the federal electionAnthony Albanese and Peter Dutton are preparing for a fresh showdown in Western Sydney. The leaders will face off tonight on the ABC, in their first free-to-air debate of this campaign. While both ...
The decades-long dream of creating a male equivalent of 'the pill' is moving closer to reality. Scientists in the US have begun testing a hormone-free contraceptive tablet in men called YCT-529.
Nytol, available in 25mg and 50mg pills, should only be taken for a maximum period of two weeks, with one tablet taken within 24-hours, according to safety guidance on the patient information leaflet.
What is the Price to Earnings Growth (PEG) Ratio? The PEG Ratio chart for Direxion Daily Pharmaceutical & Medical Bull 3x Shares (PILL) compares PE to EPS Growth rates. Defining fair value is the goal ...
Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with ...
A former Trump supporter who lost her job due to the Department of Government Efficiency's (DOGE) cuts regrets her vote. Despite positive reviews, Jennifer Piggott and other probationary employees ...
The Food and Drug Administration approved Soleno’s pill to treat hyperphagia — a condition where individuals have a sense of being hungry all the time and never feeling satisfied — in adults ...
NY Official Rejects Texas Judgment Against Doctor in Abortion Pill Case By Brendan Pierson (Reuters) -A local official in New York on Thursday rejected Texas' effort to enforce a $100,000 judgment ...
25% of women who use contraception use an oral birth control pill, but there are no equivalent methods currently available for men. Research from the University of Minnesota College of Pharmacy, ...
Merck & Co. has entered a competitive race for a new type of heart drug, announcing Tuesday it will pay China-based Jiangsu Hengrui Pharmaceuticals $200 million upfront to license a pill that ...
The company is one year into a multi-year trial, involving over 1,000 dogs to prove the long-term safety and efficacy of the pill. However, under an accelerated approval pathway, the FDA could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results